Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to Pancreatitis
Open Access
- 24 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7), e41471
- https://doi.org/10.1371/journal.pone.0041471
Abstract
Adverse drug events (ADEs) detection and assessment is at the center of pharmacovigilance. Data mining of systems, such as FDA’s Adverse Event Reporting System (AERS) and more recently, Electronic Health Records (EHRs), can aid in the automatic detection and analysis of ADEs. Although different data mining approaches have been shown to be valuable, it is still crucial to improve the quality of the generated signals. To leverage structural similarity by developing molecular fingerprint-based models (MFBMs) to strengthen ADE signals generated from EHR data. A reference standard of drugs known to be causally associated with the adverse event pancreatitis was used to create a MFBM. Electronic Health Records (EHRs) from the New York Presbyterian Hospital were mined to generate structured data. Disproportionality Analysis (DPA) was applied to the data, and 278 possible signals related to the ADE pancreatitis were detected. Candidate drugs associated with these signals were then assessed using the MFBM to find the most promising candidates based on structural similarity. The use of MFBM as a means to strengthen or prioritize signals generated from the EHR significantly improved the detection accuracy of ADEs related to pancreatitis. MFBM also highlights the etiology of the ADE by identifying structurally similar drugs, which could follow a similar mechanism of action. The method proposed in this paper provides evidence of being a promising adjunct to existing automated ADE detection and analysis approaches.Keywords
This publication has 34 references indexed in Scilit:
- Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysisJournal of the American Medical Informatics Association, 2011
- PubChem3D: Biologically relevant 3-D similarityJournal of Cheminformatics, 2011
- Discovering Disease Associations by Integrating Electronic Clinical Data and Medical LiteraturePLOS ONE, 2011
- Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting SystemClinical Pharmacology & Therapeutics, 2010
- Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methodsBlood, 2010
- Physicochemical property space distribution among human metabolites, drugs and toxinsBMC Bioinformatics, 2009
- Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility StudyJournal of the American Medical Informatics Association, 2009
- Cerulein Pancreatitis: Oxidative Stress, Inflammation, and ApoptosisGut and Liver, 2008
- Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in ChinaHepatology International, 2007
- Do Structurally Similar Molecules Have Similar Biological Activity?Journal of Medicinal Chemistry, 2002